Mandatory preoperative COVID‐19 testing for cancer patients—Is it justified?
Sri Siddhartha Nekkanti(Homi Bhabha National Institute), Sudeep Gupta(Homi Bhabha National Institute), Navin Khattry(Tata Memorial Hospital), Vedang Murthy(Homi Bhabha National Institute), Avanish Saklani(Fortis Hospital), Nikhil Patkar(Tata Memorial Hospital), Amit Joshi(Dr. Rajendra Prasad Government Medical College), Sudhir Nair(Homi Bhabha National Institute), Vani Parmar(Homi Bhabha National Institute), Nitin Shetty(Tata Memorial Hospital), Shailesh V. Shrikhande(Homi Bhabha National Institute)
Cited by 26
Related Papers
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377